Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice.
Author(s) -
Herbert C. Morse,
Janet W. Hartley,
T. N. Fredrickson,
R A Yetter,
C. Majumdar,
John L. Cleveland,
Ulf R. Rapp
Publication year - 1986
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.83.18.6868
Subject(s) - biology , recombinant dna , virology , murine leukemia virus , cancer research , cell culture , oncogene , haematopoiesis , leukemia , microbiology and biotechnology , b cell , in vitro , cell , gene , virus , immunology , genetics , stem cell , antibody , cell cycle
NFS/N mice were infected within 48 hr of birth with pseudotypes of recombinant murine leukemia viruses containing avian v-myc developed T-cell, pre-B-cell, and B-cell lymphomas and epithelial tumors including pancreatic and mammary adenocarcinomas. Primary hematopoietic and epithelial tumors and continuous in vitro cell lines derived from some of these tumors, established in the absence of added growth factors, exhibited clonal integrations of v-myc and expressed v-myc RNA. These results show that deregulated expression of the myc oncogene in mammalian cells can initiate a wide variety of neoplasms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom